0001209191-18-009019.txt : 20180209 0001209191-18-009019.hdr.sgml : 20180209 20180209194612 ACCESSION NUMBER: 0001209191-18-009019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180207 FILED AS OF DATE: 20180209 DATE AS OF CHANGE: 20180209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Secor Alicia CENTRAL INDEX KEY: 0001584516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10352 FILM NUMBER: 18593547 MAIL ADDRESS: STREET 1: 33 HAYDEN AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JUNIPER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821995 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592758596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-639-1500 MAIL ADDRESS: STREET 1: 33 ARCH STREET STREET 2: SUITE 3110 CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-07 0 0000821995 JUNIPER PHARMACEUTICALS INC JNP 0001584516 Secor Alicia C/O JUNIPER PHARMACEUTICALS INC. 33 ARCH STREET, SUITE 3110 BOSTON MA 02110 1 1 0 0 President and CEO Common Stock 2018-02-07 4 A 0 10000 0.00 A 41200 D Common Stock 2018-02-07 4 F 0 3475 8.40 D 37725 D Represents shares of JNP common stock issued upon partial vesting of a restricted stock unit award that vests upon the compensation committee's certification of the achievement of certain performance/milestone goals. The total number of shares acquired is net of the number of shares withheld for the payment of taxes. /s/ Jeffrey Young, Attorney-in-Fact 2018-02-10